Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal

PLoS Neglected Tropical Diseases

Volumn 11, Issue 9, 2017, Pages

  Upreti, Shyam Raj ^a   Lindsey, Nicole P ^b   Bohara, Rajendra ^c   Choudhary, Ganga Ram ^c   Shakya, Sushil ^c   Gautam, Mukunda ^a   Giri, Jagat Narain ^c   Fischer, Marc ^b   Hills, Susan L ^b  

^a Minister for Health and Population Nepal   (Nepal)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; SA 14 14 2 JE VACCINE; UNCLASSIFIED DRUG; LIVE VACCINE;

ADOLESCENT; ARTICLE; CHILD; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; JAPANESE ENCEPHALITIS; MAJOR CLINICAL STUDY; MORTALITY; NEPAL; PRESCHOOL CHILD; PUBLIC HEALTH CAMPAIGN; RETROSPECTIVE STUDY; SCHOOL CHILD; ANIMAL; ENCEPHALITIS, JAPANESE; EPIDEMIOLOGICAL MONITORING; FEMALE; IMMUNOLOGY; MALE; PREVENTIVE HEALTH SERVICE; VACCINATION; VIROLOGY;

ADOLESCENT; ANIMALS; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, JAPANESE; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; JAPANESE ENCEPHALITIS VACCINES; MALE; NEPAL; VACCINATION; VACCINES, ATTENUATED;

EID: 85030646585     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005866     Document Type: Article

References (17)

1. Fischer M, Lindsey N, Staples JE, Hills S, Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59: 1–27.
2. Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89: 766–774. doi: 10.2471/BLT.10.085233 22084515
3. Centers for Disease Control and PreventionJapanese encephalitis surveillance and immunization-Asia and the Western Pacific, 2012. MMWR Morb Mortal Wkly Rep. 2013;62: 658–662. 23965828
4. Tandan JB, Ohrr H, Sohn YM, Yoksan S, Ji M, Nam CM, et al. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. Vaccine. 2007;25(27):5041–5. doi: 10.1016/j.vaccine.2007.04.052 17521781
5. World Health OrganizationJapanese encephalitis vaccines: WHO position paper-February 2015. Wkly Epidemiol Rec. 2015; 90: 69–87. 25726573
6. Henderson A, Leake CJ, Burke DS, Japanese encephalitis in Nepal. Lancet. 1983;2: 359–360.
7. Joshi DD, Current status of Japanese encephalitis in Nepal. Southeast Asian J Trop Med Public Health. 1995;26(Suppl 3): 34–40.
8. Upreti SR, Janusz KB, Schluter WW, Bichha RP, Shakya G, Biggerstaff BJ, et al. Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal. Am J Trop Med Hyg. 2013;88: 464–468. doi: 10.4269/ajtmh.12-0196 23358643
9. Bista MB, Shrestha JM, Epidemiological situation of Japanese encephalitis in Nepal. J Nep Med Assoc. 2005;44: 51–56.
10. Wierzba TF, Ghimire P, Malla S, Banerjee MK, Shrestha S, Khanal B, et al. Laboratory-based Japanese encephalitis surveillance in Nepal and the implications for a national immunization strategy. Am J Trop Med Hyg. 2008;78: 1002–1006. 18541784
11. Zimmerman MD, Scott RM, Vaughn DW, Rajbhandari S, Nisalak A, Shrestha MP, Short report: an outbreak of Japanese encephalitis in Kathmandu, Nepal. Am J Trop Med Hyg. 1997;57: 283–284. 9311637
12. Bhattachan A, Amatya S, Sedai TR, Upreti SR, Partridge J, Japanese encephalitis in hill and mountain districts, Nepal. Emerg Infect Dis. 2009;15: 1691–1692. doi: 10.3201/eid1510.081641 19861079
13. World Health Organization, Program for Immunization Preventable Diseases and Child Health Division, Nepal Ministry of Health and Population. Control of Japanese Encephalitis in Nepal, 1978–2012. Available at: http://dohs.gov.np/divisions/child-health-division/
14. World Health Organization. WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases. Report No: WHO/V&B/03.01. Available at: http://www.measlesrubellainitiative.org/wp-content/uploads/2013/06/WHO-surveillance-standard.pdf. Accessed April 17, 2017.
15. Rayamajhi A, Ansari I, Ledger E, Bista KP, Impoinvil DE, Nightingale S, et al. Clinical and prognostic features among children with acute encephalitis syndrome in Nepal; a retrospective study. BMC Infect Dis. 2011; 11:294. doi: 10.1186/1471-2334-11-294 22035278
16. Le VT, Phan TQ, Do QH, Nguyen BH, Lam QB, Bach V, et al. Viral etiology of encephalitis in children in southern Vietnam: results of a one-year prospective descriptive study. PLoS Negl Trop Dis. 2010; 4: e854. doi: 10.1371/journal.pntd.0000854 21049060
17. Robertson C, Pant DK, Joshi DD, Sharma M, Dahal M, Stephen C, Comparative spatial dynamics of Japanese encephalitis and acute encephalitis syndrome in Nepal. PLoS One. 2013;8: e66168. doi: 10.1371/journal.pone.0066168 23894277